Ros Deegan

Ros Deegan

Ros Deegan is the founder of Impatient, a non-profit focused on crowdfunding Phase 2 medical trials. Ros is also head of Business Development at Trevena, a clinical-stage biopharmaceutical company in King of Prussia, PA.

Recent posts

Crowdfunding is Banging on Biotech’s Door. Will We Let It In?
In the summer of 2013, the medical device startup Scanadu made headlines around the world when Scout, its handheld medical diagnostic tool for consumers, raked in an astounding $1.6 million on... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
Navigating Challenges & Advancing Clinical Development: A Toolkit for Emerging Biotechs
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Medpace

Sponsored · Whitepaper
How Big Is the US Market for Medical Devices & Technologies?
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
IBM Watson

From Our Editors · Special Report
Xcelerating Life Sciences San Francisco: Special Report
The AI, Big Data, and R&D Boom

Xconomy on Demand

We offer a number of ways to subscribe for free!